CME Credit Available:

This activity offers .25 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Review common food reactions, understand paradigm shift in food allergy thoughts, understand the proper testing modalities for food testing.
• Review common food allergy mimickers.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Jonathan M. Horbal, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Be able to differentiate the categories and subcategories of AKI.
• Be able to differentiate the features acute vs chronic kidney disease.
• Discuss treatments for AKI including fluid management and indications for dialysis.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Mark D. Baldwin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Compare and contrast the key clinical and diagnostic features of glomerular vs tubulointerstitial diseases.
• Describe the renal manifestations of multiple myeloma.
• Discuss the pathophysiology and treatment of hypercalcemia of malignancy.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Mark D. Baldwin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Understand the clinical approach to proliferative glomerulonephritis.
• Understand the value of renal biopsy.
• Understand the workup for hematuria.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Discuss the key diagnostic features of Syndrome of inappropriate ADH secretion and appropriate treatments.
• Explain the key diagnostic features of central and nephrogenic diabetes insipidus and appropriate treatments.
• Identify the key diagnostic features of Gitelman's and Bartter's syndromes.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Mark D. Baldwin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Understand the approach to gapped metabolic acidosis.
• Understand the use of the urine anion gap.
• Understand the diagnosis and treatment approach to metabolic alkalosis.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Understand of guideline-based treatment for hypertension.
• Understand the place of the SPRINT Trial in relation to hypertension treatment goals.
• Understand the workup for hypertension.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• How to work up an Acute Neuropathy for the boards.
• How to work up and diagnose a Polyneuropathy for the boards.
• How to recognize and diagnose a Mononeuropathy multiplex for the boards.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Diagnose selected genetic conditions.
• Anticipate selected conditions based upon patients’ genetics disorders.
• Correlate genetic inheritance with selected conditions.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Robert T. Hasty, DO, FACOI, FACP, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.

CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Overview of headaches and treatment for the Boards.
• Review of Parkinson's, seizures, and motor disorders for the Boards.
• Overview of myopathies and treatments for the Boards.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from May 13, 2023, until May 13, 2026.